MYWF main aim is serving the Humanity, we worked for the flood victims last year and currently MYWF is doing free treatments of poor patients having Hepatits and cannot afford to do treatment, our next step will be to start working on constructing a hospital inshAllah, basically for Hepatitis treatment at NO COST. Especially since this disease will be commonly spread among the Victims who had to spend their days and nights unwillingly in the camps.
As one out of 10 Pakistani suffers from the virus of either Hepatitis B or C, the hepatitis-infected population of 15 million awaits the proper implementation of a National Programme for Prevention and Control of Hepatitis in Pakistan to control the deadly disease.
Unsafe drinking water, unscreened blood transfusion and the rampant use of used syringes have spread hepatitis, making it one of the biggest concerns for the country's health managers.
Our aim is to launch MYWF Programme for Prevention and Control of Hepatitis in Pakistan.
The major components of the Programme includes:
safe drinking water
safe blood transfusion
behaviour change communication
safe disposal of injection
invasive devices
capacity building
vaccination of high risk groups and free treatment for patients
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close